Navigation Links
Dialysis Patient Citizens Welcomes New Members to Board of Directors
Date:9/2/2008

Educating Americans about the Importance of Kidney Health Remains Key Element for Organization

WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- Dialysis Patient Citizens (DPC) -- a nationwide, non-profit patient advocacy group comprised of more than 23,000 dialysis and pre-dialysis patients and family members working to advance the quality of life of dialysis patients -- announced this month the addition of three new board members -- Dr. Gene Copello, of Washington, D.C.; Erich Ditschman, of East Lansing, MI; and Nancy Scott, of New Castle, DE. All newly appointed members come to the board with a wealth of experience in the kidney environment where they have worked to understand the issues of importance to dialysis patients and the difficulties patients sometimes face.

Dr. A. Gene Copello has 25 years of public health program and public policy experience. He is the Executive Director of The AIDS Institute, a national nonprofit and nonpartisan public policy research, advocacy, and education organization. The agency is affiliated with the University of South Florida where Dr. Copello is an Assistant Professor in the College of Medicine, Division of Infectious Diseases and International Medicine. Previously, Dr. Copello served as Chief of HIV Services for the City of San Francisco and as Executive Director of the San Mateo County AIDS Program in California. He began his career in HIV/AIDS as a faculty member at the Vanderbilt University School of Medicine, where he also founded and directed the Vanderbilt AIDS Project.

Erich Ditschman, of East Lansing, MI, is the former President/CEO of Clinton River Watershed Council. Ditschman has been involved with DPC for years through his work as a DPC Patient Ambassador. He has met with Congressional leaders and staff in Washington, D.C. and over the past six years, has organized a team for the Mid Michigan Walk, which has raised over $42,000 for the National Kidney Foundation of Michigan. A home hemo di
'/>"/>

SOURCE Dialysis Patient Citizens
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Clinical trials present better alternatives for dialysis patients
2. Nighttime Home Dialysis a Boon for Kidney Patients
3. Nations Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care
4. WellBound Teams With Kaiser Permanente to Open New Self-Care Dialysis Center in Sacramento, CA
5. New peritoneal dialysis diagnostic discovered
6. Early intervention dramatically improves outcomes for new dialysis patients
7. Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date
8. Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis
9. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
10. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
11. Home Dialysis Clinical Research Study is Underway - Focuses on At-Home Extended Duration Treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , ANN ARBOR, Mich., Dec. 3 A...n healthcare reform legislation, but most lack con...lity of medical care will improve in the next year...Reuters. ,, Sixty percent of survey respondents...ded in final healthcare reform legislation. Only a...
(Date:12/2/2009)... , MINNEAPOLIS, Dec. 3 /PRNewswire-USNewswire/...ters (AAPCC) has designated Hennepin Regional Pois...ed poison control center - a major milestone for t...e Hennepin Regional Poison Center among 58 accredi...creditation represents a major accomplishment. It ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Repo...report is available in its catalogue: ,, Kina....reportlinker.com/p0166819/Kinase-Inhibitors-Globa...arket, providing data for the years 2005 through 2...nnual growth rates (CAGRs) through 2014 ,, An ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Repor...eport is available in its catalogue: ,, Antibi...l Markets ,, http://www.reportlinker.com/p016...gies-Global-Markets.html ,, Provide an in-dept...stance and antibiotics technologies ,, Offer an...
(Date:12/2/2009)... , BOSTON, Dec. 2 The...e traffic rises 8%. According to Coremetrics, a m... 13.7 percent on Cyber Monday compared to Cyber Mo...on,s Bella Sante Day Spas who reported today "Cy...ay Internet sales rose 59%" - said Tiffany Amorosi...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 2Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3
...in the presence of disinfecting solutions , ...ation is common in contact lens storage cases, say...en in two-thirds of 30 storage cases used by 16 pe... was the most common type of pathogen (41 percent)...
...today announced it has filed,an additional law sui...t,Genesis Pharmaceuticals (OTC Bulletin Board: GNP... (GTEC) and Genesis Equity Partners II (GEP II) fo...due under,the note. , GEP II borrowed $190,0...
...27, 2008 Suffering from end-stage renal disease ... hospitalier de l,Universit de Montral (CHUM), hav...akthrough: high efficacy hemodiafiltration (HDF). ..., preliminary results show a clear advantage of hi...
...ety of general vs. local delivery , , WEDN...rgery to treat carotid (neck) artery blockages are...nesthesia, according to a study by U.K. researcher...eries increase the risk of stroke, and a procedure...
... aged care nurses are considering quitting in the ...sity of Melbourne study. , The study, conducted b...University of Melbourne and the Australian Nursing...cites excessive workloads, cost cutting, a hostile...
...wswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.,(NYS... and medical device,research and development outso...ited States, today announced Edward Hu, the Compan...tandard Time. , (Photo: http://www.newscom....
Other Medicine News:Health News:Contact Lens Cases Often Contaminated 2Health News:China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details 2Health News:Major North American breakthrough for dialysis patients 2Health News:Major North American breakthrough for dialysis patients 3Health News:Anesthesia Type Won't Influence Neck Artery Surgery Outcomes 2Health News:Aged care workers to leave industry en masse due to stress, warns University of Melbourne study 2Health News:WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference 2
(Date:12/2/2009)... 2 Reportlinker.com announces that...catalogue: ,, Multiple Myeloma Therapeutics -...ww.reportlinker.com/p0164271/Multiple-Myeloma-Ther...Given the severity, and relentless relapses of the...and treatments to battle the disease and improve p...
(Date:12/2/2009)... 2 Reportlinker.com announces that...catalogue: ,, Global Markets for Asthma and C...66826/Global-Markets-for-Asthma-and-COPD-Drugs.htm...al market for medications that treat asthma and ch... global market forecasts through 2014 for medicati...
(Date:12/2/2009)...ec. 2 Abbott,s Ibis tech...ay of microorganisms has been named one of the top... A panel of expert judges evaluated a broad range ...,s top innovations, with the winners unveiled in t...w.the-scien t ist.com/top10innovations . ,, ...
Breaking Medicine Technology:Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 2Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 3Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 4Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 5Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 6Reportlinker Adds Global Markets for Asthma and COPD Drugs 2Reportlinker Adds Global Markets for Asthma and COPD Drugs 3Reportlinker Adds Global Markets for Asthma and COPD Drugs 4Reportlinker Adds Global Markets for Asthma and COPD Drugs 5Reportlinker Adds Global Markets for Asthma and COPD Drugs 6Reportlinker Adds Global Markets for Asthma and COPD Drugs 7Reportlinker Adds Global Markets for Asthma and COPD Drugs 8Reportlinker Adds Global Markets for Asthma and COPD Drugs 9Reportlinker Adds Global Markets for Asthma and COPD Drugs 10Reportlinker Adds Global Markets for Asthma and COPD Drugs 11Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist 2Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 1Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 2Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 3Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 4Health Plans Prepare for Health Care Reform 3A Comparative Effectiveness Consumerism Drive Future Changes According to Deloitte Study 47924 5MD On Line Inc Acquires Medical Claim Corp 47920 1MD On Line Inc Acquires Medical Claim Corp 47920 2Study gives clues to how adrenal cancer forms 47919 1Study gives clues to how adrenal cancer forms 47919 2
... Study Seeks to Enroll 750 Women at More Than 100 ...tRx Pharmaceuticals, a,privately-held biopharmaceu...lization of compounds to treat endocrine, metaboli...at it has initiated a second,Phase 3 clinical tria...s,estrogen-free oral therapy in development for th...
... Survival Data for Ipilimumab to be Presented, PR...DX ) announced today that nine clinical abstracts ...body, in melanoma are scheduled to be,the subject ...ean Society,for Medical Oncology (ESMO) being held...ollowing abstracts will include updated one-year s...
Other Medicine Technology:QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3
Blade Holder
Reveal XVI
...k's ophthalmic Nd: YAG laser YC-1600 is a lightwei...versatility and clinical performance., ,Key Fe..., Lightweight Model ,Further weight reduction...in your office.,, Aiming Beam Rotation ,...
...eart of the innovative EUS EXERA system from Olymp...formance to meet all of your observation and diagn...nic gastrovideoscope, the EU-M60 allows for increa...the body and greater resolution allowing you to fo...
Medicine Products: